Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jon Blatchford"'
Autor:
Afshin Salsali, João Pedro Ferreira, Mitchell A. Psotka, Martina Brueckmann, Mikhail Kosiborod, Jan Biegus, Adriaan A. Voors, Claudia Grauer, Christiane E. Angermann, John R. Teerlink, Jon Blatchford, Sean P. Collins, Piotr Ponikowski, Michael E. Nassif, Jasper Tromp
Publikováno v:
European Journal of Heart Failure, 23(5), 826-834. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2137⟩
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2137⟩
International audience; Aims: Treatment with sodium-glucose co-transporter 2 (SGLT2) inhibitors improves outcomes in patients with chronic heart failure (HF) with reduced ejection fraction. There is limited experience with the in-hospital initiation
Autor:
Adriaan Voors, Christiane Angermann, John Teerlink, Sean Collins, Mikhail Kosiborod, Jan Biegus, Joao Pedro Ferreira, Michael Nassif, Mitchell Psotka, Jasper Tromp, Martina Bruekmann, Jon Blatchford, Afshin Salasali, Piotr Poniikowski
Publikováno v:
Heart & Lung. 55:172
Autor:
Stéphane Champiat, Philippe A. Cassier, Jon Blatchford, Mabrouk Elgadi, Armelle Vinceneux, Nuria Kotecki, Christiane Jungels, Jean-Pierre Delord, Bérangère Vasseur, Nicole Clarke, Iphigenie Korakis, Aurélien Marabelle, Claudia Fromond, Nicolas Poirier
Publikováno v:
Journal of Clinical Oncology. 39:2623-2623
2623 Background: BI 765063 is a humanized IgG4 monoclonal antibody antagonist of SIRPα (Signal Regulatory Protein α), which blocks the “don't eat me” signal of the SIRPα/CD47 axis, a critical innate immune checkpoint. SIRPα is expressed on my
Autor:
Abhya Gupta, Rüdiger Koenen, Dominik Kappeler, Andy Fowler, Ewald Benediktus, Chester C. Wood, James Hilbert, Jon Blatchford
Publikováno v:
The Journal of Clinical Pharmacology. 57:1444-1453
BI 1021958, a novel antagonist of the chemoattractant-receptor-homologous molecule (CRTH2), targets airway inflammation in asthma by inhibiting prostaglandin binding to CRTH2 receptors. Two phase 1 studies assessed BI 1021958 safety/tolerability and
Autor:
Ph. Gabriel Steg, Savion Gropper, Deepak L. Bhatt, Christopher P. Cannon, Jon Blatchford, Ernesto Ferreiros Ripoll, Stefan H. Hohnloser, Jenny Manassie, Jonas Oldgren, Takeshi Kimura, Gregory Y.H. Lip, Jörg Kreuzer, Joseph M. Massaro, Martina Brueckmann, Jurriën M. ten Berg, Stephen G. Ellis
Publikováno v:
Clinical Cardiology
Antithrombotic management of patients with atrial fibrillation (AF) undergoing coronary stenting is complicated by the need for anticoagulant therapy for stroke prevention and dual antiplatelet therapy for prevention of stent thrombosis and coronary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a44e51a107ed6cf6e93ab235b23a322
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-311601
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-311601
Autor:
Ralph, Weber, Christian, Weimar, Jon, Blatchford, Karin, Hermansson, Isabel, Wanke, Claudia, Möller-Hartmann, Elke R, Gizewski, Michael, Forsting, Andrew M, Demchuk, Ralph L, Sacco, Jeffrey L, Saver, Steven, Warach, Hans-Christoph, Diener, Anke, Diehl, Erfan, Albakri
Publikováno v:
Stroke. 43:2336-2342
Background and Purpose— High blood pressure is one of the main risk factors for cerebral white matter lesions (WMLs). There is limited evidence from one randomized trial that blood pressure-lowering is able to slow WML progression. We investigated
Autor:
John W, Eikelboom, Stuart J, Connolly, Martina, Brueckmann, Christopher B, Granger, Arie P, Kappetein, Michael J, Mack, Jon, Blatchford, Kevin, Devenny, Jeffrey, Friedman, Kelly, Guiver, Ruth, Harper, Yasser, Khder, Maximilian T, Lobmeyer, Hugo, Maas, Jens-Uwe, Voigt, Maarten L, Simoons, Frans, Van de Werf, J, Rogowski
Publikováno v:
New England Journal of Medicine, 369(13), 1206-1214. Massachussetts Medical Society
New England journal of medicine, 369(13), 1206-1214. Massachussetts Medical Society
New England journal of medicine, 369(13), 1206-1214. Massachussetts Medical Society
BackgroundDabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves. MethodsIn this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4d96d1188472d4b299f2fb1f5268a2
https://pure.eur.nl/en/publications/1274a6e4-557a-4f4a-8a19-5e00d49fbd23
https://pure.eur.nl/en/publications/1274a6e4-557a-4f4a-8a19-5e00d49fbd23
Autor:
Elke R. Gizewski, Isabel Wanke, Hans-Christoph Diener, Christian Weimar, Steven Warach, Ralph Weber, Jeffrey L. Saver, Michael Forsting, Jon Blatchford, Andrew M. Demchuk, Claudia Möller-Hartmann, Anke Diehl, Karin Hermansson, Ralph L. Sacco
Background and Purpose— Silent brain infarctions are associated with an increased risk of stroke in healthy individuals. Risk of recurrent stroke in patients with both symptomatic and silent brain infarction (SBI) has only been investigated in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1960e1c934ee479a12035e8bf3321744
https://www.ncbi.nlm.nih.gov/pubmed/22267825
https://www.ncbi.nlm.nih.gov/pubmed/22267825
Autor:
Demetri Pavia, Eric D. Bateman, David Smith, Bernd Disse, Lesley Towse, Dave Singh, Dan Massey, Jon Blatchford, Rick Hodder
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease.
Eric Bateman1, Dave Singh2, David Smith3, Bernd Disse4, Lesley Towse5, Dan Massey5, Jon Blatchford5, Demetri Pavia5, Rick Hodder61Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa; 2University Hospital